The cancer, anaplastic large cell lymphoma occurs in the breast occurs in three out of every 100 million women per year worldwide.

FORBES: What the Numbers Really Say About Breast Implants and Cancer

The expert group did find an increased risk of one extremely rare cancer - anaplastic large cell lymphoma (ALCL) from all breast implants.

BBC: How France and UK differ on implants

Separately, Pfizer said that the Food and Drug Administration has approved Xalkori capsules, which the company calls the first-ever drug targeting anaplastic lymphoma kinase, or ALK, for the treatment of locally advanced or metastatic non-small cell lung cancer that is ALK-positive.

FORBES: Bristol-Myers, Pfizer Announce Positive Results; An FDA Approval for Pfizer